Literature DB >> 6403266

Separation of two molecular species of the Sm antigen by affinity chromatography with murine monoclonal and human anti-nuclear autoantibodies.

R R Buchanan, P J Venables, A Morgan, N A Staines, P R Smith, R N Maini.   

Abstract

Nuclear ribonuclear protein (nRNP) and Sm were extracted from a 30-60% ammonium sulphate fraction of rabbit thymus extract by affinity chromatography. Immunoadsorbent columns were prepared from IgG extracted from an anti-nRNP serum, an anti-Sm serum and two monoclonal autoantibodies derived from a MRL/lpr mouse. All four immunoadsorbents isolated both nRNP and Sm antigens indicating that they exist as the 'nRNP/Sm complex' A species of Sm which did not bind to the anti-nRNP column and which was subsequently purified with the anti-Sm column was termed 'free Sm'. The Sm in the complex and free Sm were immunologically identical on immunodiffusion and gave similar polypeptide bands on polyacrylamide gel electrophoresis. However, they differed in that complexed Sm was sensitive to heat and RNAase. These studies provide direct evidence of a physical association between the nRNP and Sm antigens and indicate an additional molecular species of Sm whose resistance to RNAase may be due to different associated RNA species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403266      PMCID: PMC1536750     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Profiles of antinuclear antibodies in systemic rheumatic diseases.

Authors:  D D Notman; N Kurata; E M Tan
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Physical association of two nuclear antigens and mutual occurrence of their antibodies: the relationship of the SM and RNAprotein (MO) systems in SLE sera.

Authors:  M Mattioli; M Reichlin
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

4.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

5.  Definition of the antigenic polypeptides in the Sm and RNP ribonucleoprotein complexes.

Authors:  P J White; S O Hoch
Journal:  Biochem Biophys Res Commun       Date:  1981-09-16       Impact factor: 3.575

6.  Nuclear antigens: characterization of the acidic nuclear ribonucleoprotein-Sm-antigen complex by analytical and preparative isoelectric focusing.

Authors:  E R Waelti; M W Hess
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

Authors:  E M Tan; H G Kunkel
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

8.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes.

Authors:  P J Venables; C C Erhardt; R N Maini
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

10.  Purification and biochemical characterization of nuclear ribonucleoprotein antigen using purified antibody from serum of a patient with mixed connective tissue disease.

Authors:  M Takano; P F Agris; G C Sharp
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

View more
  15 in total

1.  Rapid clearance of the lupus antigen Sm is delayed by autoantibody: a possible mechanism of autoimmunity perpetuation.

Authors:  M Field; R D Melsom; F M Brennan; D G Williams; L Schreiber; D A McCarthy; R N Maini; R D Nelsom
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

2.  Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides.

Authors:  D G Williams; M R Stocks; P R Smith; R N Maini
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

3.  Autoimmunity to La (SS-B) in vitro is related to HLA-DR3 in healthy subjects.

Authors:  P J Venables; S Rigby; P A Mumford; J Markwick; R N Maini
Journal:  Ann Rheum Dis       Date:  1988-01       Impact factor: 19.103

Review 4.  Purification of antigens and monoclonal antibodies.

Authors:  D Williams
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

5.  Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody.

Authors:  K M Pollard; E M Tan
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

6.  Identification and purification of a 55K polypeptide in Sjögren's syndrome A antigen.

Authors:  P R Smith; P J Venables; D Williams; R N Maini
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

7.  Individual variation of anti-Sm autoantibodies in the MRL/MP-lpr/lpr mouse: age-related increase in diversity.

Authors:  D G Williams; F M Brennan; M R Stocks; R N Maini
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

8.  Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.

Authors:  M Zouali; A Eyquem
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

9.  Antibodies to nRNP, Sm, Ro(SSA) and La(SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease sera.

Authors:  P J Maddison; R P Skinner; P Vlachoyiannopoulos; D M Brennand; D Hough
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

10.  Purification and characterization of the Sjögren's syndrome A and B antigens.

Authors:  P J Venables; P R Smith; R N Maini
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.